Characterisation of the effects of natriuretic peptides upon ACTH secretion from the mouse pituitary

Molecular and Cellular Endocrinology

Volumn 152, Issue 1-2, 1999, Pages 11-19

  Guild, Simon B ^a   Cramb, Gordon ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

ACTH; Anterior pituitary (mouse); cGMP; Natriuretic peptides; Receptor expression

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CORTICOTROPIN; NATRIURETIC PEPTIDE TYPE C;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORTICOTROPIN RELEASE; HORMONAL REGULATION; HORMONE INHIBITION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; REGULATORY MECHANISM; SECOND MESSENGER;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; PITUITARY GLAND; RADIOIMMUNOASSAY;

EID: 0033603462     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00068-4     Document Type: Article

References (63)

1. Abou-Samra A-B., Catt K.J., Aguilera G. Calcium-dependent control of corticotropin release in rat anterior pituitary cell cultures. Endocrinology. 121:1987a;965-971.
2. Abou-Samra A-B., Catt K.J., Aguilera G. Synthetic atrial-natriuretic factors (ANFs) stimulate guanine 3′, 5′-monophosphate production but not hormone release in rat pituitary cells: peptide contamination with a gonadotropin-releasing hormone agonist explains luteinizing hormone-releasing activity of certain ANFs. Endocrinology. 120:1987b;18-24.
3. Aiton J.F., Simmons N.L. Effect of ouabain upon diuretic-sensitive K and transport in cultured cells-evidence for separate modes of operation of the transporter. Biochem. Biophys. Acta. 734:1983;279-289.
4. Anand-Srivastava M.B., Cantin M., Genest J. Inhibition of pituitary adenylate cyclase by atrial natriuretic factor. Life Sci. 36:1985;1873-1879.
5. Anand-Srivastava M.B., Sehl P.D., Lowe D.G. Cytoplasmic domain of natriuretic peptide receptor-C-inhibits adenylyl-cyclase-involvement of a pertussis toxin-sensitive G-protein. J. Biol. Chem. 271:1996;19324-193239.
6. Antoni F.A., Dayanithi G. Guanosine 3′:5′ cyclic monophosphate and activators of guanylate cyclase inhibit secretagogue-induced corticotrophin release by rat anterior pituitary cells. Biochem. Biophys. Res. Commun. 158:1989;824-830.
7. Antoni F.A., Hunter E., Lowry P.J., Noble J.M., Seckl J.R. Atriopeptin-an endogenous corticotrophin-release inhibiting hormone. Endocrinology. 130:1992;1753-1755.
8. Axelrod J., Reisine T. Stress hormones: their interaction and regulation. Science. 224:1984;452-459.
9. Bowman M.E., Robinson P.J., Smith R. Atrial natriuretic peptide, cyclic GMP and modulation of guanylyl cyclase do not alter stimulated POMC peptide release from perifused rot or sheep corticotrophs. J. Neuroendocrinol. 9:1997;929-936.
10. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein bye binding. Anal. Biochem. 72:1976;248-254.
11. Cathala G., Savouret J-F., Mendez B. et al. Laboratory methods - a method for isolation of intact translationally active ribonucleic acid. DNA. 2:1983;329-335.
12. Chinkers M., Garbers D.L., Chang M-S. et al. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature (London). 338:1989;78-83.
13. Dayanithi B., Antoni F.A. Atriopeptides are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro: involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase. J. Endocrinol. 125:1990;39-44.
14. Feinberg A.P., Vogelstein B. Technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
15. Fink G., Dow R.C., Casley D. et al. Atrial-natriuretic-peptide is a physiological inhibitor of ACTH release; evidence from immunoneutralization in vivo. J. Endocrinol. 131:1991;R9-R12.
16. Fink G., Dow R.C., Casley D. et al. Atrial-natriuretic-peptide is involved in the ACTH response to stress and glucocorticoid negative feedback in the rat. J. Endocrinol. 135:1992;37-43.
17. Flynn T.G., de Bold M.L., de Bold A.J. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem. Biophys. Res. Commun. 117:1983;859-865.
18. Franci C.R., Anselmo F.J., McCann S.M. The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotrophin, prolactin, growth hormone and thyroid-stimulating hormone. Proc. Natl. Acad. Sci. USA. 89:1992;11391-11395.
19. Geiger H., Bahner U., Palkovits M., Hempel K. effect of atrial natriuretic peptide on the adenylate cyclase activity in the anterior and neurointerrnediate lobes of rats. Miner. Electrolyte Metab. 16:1990;38-41.
20. Gilkes A.F., Mackay K.B., Cramb G., Guild S.B. Altered natriuretic peptide signal-transduction mechanisms in AtT-20 tumour cells. Mol. Cell. Endocrinol. 89:1992;39-45.
21. Gilkes A.F., Ogden P.H., Guild S.B., Cramb G Characterisation of natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour cell line. Biochem. J. 299:1994a;481-487.
22. Gilkes A.F., Guild S.B., Cramb C. Phorbol ester activation of protein kinase C inhibits CNP-stimulated cyclic GMP production in the mouse AtT20 pituitary tumour cell line. Biochem. Biophys. Res. Commun. 204:1994b;1318-1324.
23. Gutkowska J., Nemer M. Structure, expression and function of atrial natriuretic factor in extra-atrial tissues. Endocr. Rev. 10:1989;519-536.
24. Gutkowska J., Antunes-Rodrigues J., McCann S.M. Atrial natriuretic peptide in brain and pituitary gland. Physiolog. Rev. 77:1997;465-515.
25. Hartt D.J., Ogiwara T., Ho A.K., Chik C.L. Cyclic-GMP stimulates growth-hormone release in rat anterior pituitary-cells. Biochem. Biophys. Res. Commun. 214:1995;918-926.
26. Heisler S., Simard J., Assayag E., Mehri Y., Labrie F. Atrial natriuretic factor does not affect basal, forskolin- and CRF-stimulated adenylate cyclase activity, cAMP formation or ACTH secretion, but does stimulate cGMP synthesis in anterior pituitary. Mol. Cell. Endocrinol. 44:1986;125-131.
27. Herman J.P., Dolgas C.M., Rucker D., Langub M.C.I. Localisation of natriuretic peptide-activated guanylate-cyclase messenger-RNAs in the rat-brain. J. Comp. Neurol. 369:1996;165-187.
28. Huang F.L.S., Skala K.D., Samson W.K. C-type natriuretic peptide stimulates prolactin secretion by a hypothalamic site of action. J. Neuroendocrinol. 4:1992;593-597.
29. Itoh H., Nakao K., Katsuura G. et al. Centrally infused atrial natriuretic polypeptide attenuates exaggerated salt appetite in spontaneously hypertensive rats. Circ. Res. 59:1986;342-347.
30. Jacobowitz D.M., Skofitsch G., Keiser R.R., Eskay R.L., Zamir N. Evidence for the existence of atrial natriuretic factor-containing neurones in the rat brain. Neuroendocrinology. 40:1985;92-94.
31. Kellner M., Wiedemann K., Holsboer F. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci. 50:1992;1835-1842.
32. King M.S., Baertschi A.J. Physiological concentrations of atrial natriuretic factors with intact N-terminal sequences inhibit corticotrophin-releasing factor-stimulated adrenocorticotrophin secretion from cultured anterior pituitary cells. Endocrinology. 124:1989;286-292.
33. Koch B., Boudjada T., Lutz-Bucher B. Characterisation of high affinity receptor sites for atrial natriuretic factor in anterior pituitary gland: evidence for the existence of two receptor forms. Biochem. Biophys. Res. Commun. 152:1988;904-909.
34. Kojima M., Minamino N., Kangawa K, Matuso H. Cloning and sequence-analysis of a cDNA encoding a precursors for rat C-type natriuretic peptide (CNP). FEBS Letts. 276:1990;209-213.
35. Konrad E.M., Thibault G., Schiffrin E.L. Autoradiographic localisation of the natriuretic peptide receptor-B in rat tissues. Regul. Pept. 39:1992;177-189.
36. Kurihara M., Saavedra J.M., Shigematsu K. Localisation and characterisation of atrial natriuretic peptide binding sites in discrete areas of rat brain and pituitary gland by quantitative autoradiography. Brain. Res. 408:1987;31-35.
37. Langub M.C., Watson R.E., Herman J.P. Distribution of natriuretic peptide precursor messenger-RNAs in the rat-brain. J. Comp. Neurol. 356:1995;183-199.
38. Luckman S.M., Bicknell R.J. Binding-sites for atrial-natriuretic-peptide (ANP) on cultured pituicytes-lack of effect of ANP on release of neurohypophyseal hormones in vitro. Neurosci. Lett. 123:1991;156-159.
39. Maack T., Suzuki M., Almeida F.A. et al. Cyclic guanosine-monophosphate production in the pituitary; stimulation by C-type natriuretic peptide and inhibition by Gonadotrophin-releasing-hormone in alpha-t3-1 cells. Endocrinology. 132:1993;2065-2072.
40. McArdle C.A., Poch A., Kappler K. Cyclic guanosinemonophosphate production in the pituitary -stimulation by C-type natriuretic peptide and inhibition by gonadotropin-releasing-hormone in alpha-T3-1 cells. Endocrinology. 132:1993;2065-2072.
41. McArdle C.A., Ivell R., Kappler K. et al. Production and action of C-type natriuretic peptide in the gonadotrope-derived alpha-T3-1 cell-line. Endocrine. 2:1994a;849-856.
42. McArdle C.A., Olcese J., Schmidt C., Poch A., Kratzmeier M., Middendorff R. C-type natriuretic peptide (CNP) in the pituitary-is CNP an autocrine regulator of gonadotrophs. Endocrinology. 135:1994b;2794-2801.
43. McCartney S., Cramb G. Effects of a high-salt diet on hepatic atrial natriuretic peptide receptor expression in Dahl salt-resistant and salt-sensitive rats. J. Hypertens. 11:1993;253-262.
44. McFerran B.W., Guild S.B. The roles of adenosine 3′, 5′-cyclic monophosphate (cAMP)-dependent protein kinase (PKA) and protein kinase C (PKC) in stimulus-secretion coupling in AtT-20 cells. J. Mol. Endocrinol. 16:1996;133-140.
45. Mulligan R.S., Livesey J.H., Evans M.J., Ellis M.J., Donald R.A. Atrial natriuretic and C-type natriuretic peptide do not acutely inhibit the release of adrenocorticotrophin from equine pituitary cell in vitro. Neuroendocrinology. 65:1997;64-69.
46. Ohta S., Shimekake Y., Nagata K. Cell-type-specific function of the C-type natriuretic peptide gene promoter in rat anterior pituitary-derived cultured-cell lines. Mol. Cell. Biol. 113:1993;4077-4086.
47. Porter J.G., Arfsten A., Fuller F., Miller J.A., Gregory L.C., Lewicki J.A. Isolation and functional expression of the human atrialnatriuretic-peptide clearance receptor cDNA. Biochem. Biophys. Res. Commun. 171:1990;796-803.
48. Quirion R., Dalphe M., De Lean A., Gutkowska J., Cantin M., Genest J. Atrial natriuretic factor (ANF) binding sites in brain and related structures. Peptides. 5:1984;1167-1172.
49. Richman R.A., Kopf G.S., Hamet P., Johnson R.A. Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates. J. Cycl. Nucleotide Res. 6:1980;461-468.
50. Sabol S.L. Storage and secretion of β-endorphin and related peptides by mouse pituitary tumour cells: regulation by glucocorticoids. Archiv. Biochem. Biophys. 203:1980;37-48.
51. Sakata J., Shimokubo T., Kitamura K. et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS. Letts. 352:1994;105-108.
52. Samson W.K., Murphy T., Schell D.A. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotrophin release. Endocrinology. 136:1995;2349-2352.
53. Samson W.K. Atrial natriuretic factor inhibits dehydration and haemorrhage-induced vasopressin release. Neuroendocrinology. 40:1985;277-279.
54. Schulz S., Singh S., Bellet R.A. et al. The primary structure of a plasma-membrane guanylate-cyclase demonstrates diversity within this new receptor family. Cell. 58:1989;1155-1162.
55. Shibasaki T., Naruse M., Naruse K. et al. Rat atrial natriuretic factor suppresses proopiomelanocortin-derived peptides secretion from both anterior and intermediate lobe cells and growth hormone release from anterior lobe cells of rat pituitary in vitro. Biochem. Biophys. Res. Commun. 136:1986;590-594.
56. Shimekake Y., Ohta S., Nagata K. C-type natriuretic peptide stimulates secretion of growth hormone from rat-pituitary-derived GH3 cells via a cyclic GMP-mediated pathway. Eur. J. Biochem. 222:1994;645-650.
57. Steele M.K. Additive effects of atrial-natriuretic-peptide and angiotensin-II on luteinising-hormone and prolactin-release in female rats. Neuroendocrinology. 51:1990;345-350.
58. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature. 332:1988;78-81.
59. Tan T.T, Tyang Z, Huang W., Lim A.T. ANF (1-28) is a potent suppressor of pro-opiomelanocortin (POMC) mRNA but a weak inhibitor of β-EP-1 release from AtT-20 cells. J. Endocrinol. 143:1994;R1-R4.
60. Titake K., Share L., Crofton J.T., Brooks D.P., Ouchi Y., Blaine E.H. Central atrial natriuretic factor reduces vasopressin secretion in the rat. Endocrinology. 119:1986;438-440.
61. Vlsakovska M., Hertting G., Knepel W. Adrenocorticotrophin and β-Endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotrophin-releasing factor. Endocrinology. 115:1984;895-903.
62. Wilcox J.H., Augustine A., Goeddel D.V., Lowe D.G. Differential regional expression of the three natriuretic peptide receptor genes within primate tissues. Mol. Cell. Biol. 11:1991;3454-3462.
63. Zamir N., Skofitsch G., Eskay R.L., Jacobowitz D. Distribution of immunoreactive atrial natriuretic peptides in central nervous system of the rat. Brain. Res. 365:1986;105-110.